Mr. Gavin Bogle reports

BLUEOCEAN NUTRASCIENCES INC. BUYS 100% OF JOINT VENTURE AND PROVIDES A CORPORATE UPDATE

Blueocean NutraSciences Inc., effective July 11, 2015, has agreed to buy the Quinlan Brothers Ltd.'s 50-per-cent share of 70717 Newfoundland and Labrador Inc. for a nominal amount. After the close of the transaction, 70717 will become a wholly owned subsidiary of Blueocean. Blueocean and Quinlan agree that the purpose and the underlying economics of the current joint venture structure are not sustainable. Going forward, Blueocean will be free to source North Atlantic shrimp feedstock from multiple sources without restriction for its proprietary North Atlantic shrimp oil products.

Company update

Blueocean is currently marketing shrimp oil sourced from both the North Atlantic and the South Pacific, and has provided numerous samples to interested potential customers.

Blueocean is currently marketing its new sustained-release astaxanthin and omega-3 shrimp oil tablets to supplement companies. In addition, Blueocean has formulated sustained-release omega-3 fish oil tablets and is providing samples to a select group of interested supplement companies.

Blueocean and its joint venture partner, CMAX Technologies Inc., have also developed an omega-3 drink, which the company will begin marketing in third quarter 2015.

The company is still on track to begin bioavailability trials of its sustained-release fish oil tablets during third quarter 2015.

We seek Safe Harbor.